Metode Validasi Analisis Senyawa Kimia Obat dalam Sampel Biologis (Plasma Darah)
DOI:
https://doi.org/10.46799/jhs.v3i5.489Keywords:
Methods for validation of chemical compound analysis;, blood plasma;, validation of chemical compounds;Abstract
Blood plasma is used as a biological sample in determining the levels of drug compounds because the concentration of the drug will bind to its receptors and determine the size of the pharmacological effect of a drug. The purpose of this study was to determine the accuracy of human blood plasma as a sample in several validation methods with different analytes. The research method used is by conducting a literature study in several credible journals with the criteria of the journals of the last 10 years regarding the determination of levels of drug compounds in human blood. The results obtained from five different analytes, namely glibenclamide combination with metformin, formalin, vancomycin, lisinopril and a-mangostin which have been validated using various validation methods, namely SPE-MIP followed by HPLC, UV-VIS spectrophotometer, HPLC-UV, UPLC and TLC densitometry using human blood plasma samples, all meet the validation requirements. So it can be concluded that, human blood plasma used as a sample in the validation test with various different methods and analytes that have been carried out is entirely accurate because all validation test methods meet the requirements
Published
Versions
- 2022-05-24 (2)
- 2022-05-24 (1)
Issue
Section
License
Copyright (c) 2022 Fira Aulia Fatan, Gisel Rizuna Qothrunnada, Issabella Elsiana, Kholifatul Ulum, Klaritya Anisya Kurnia, Shafa Qotrunnada Widyatamaka, Shipa Paujiah
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under aCreative Commons Attribution-ShareAlike 4.0 International (CC-BY-SA). that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
